Impaired lymphoid organ development in mice lacking the heparan sulfate modifying enzyme glucuronyl C5-epimerase

Journal of Immunology

Volumn 184, Issue 7, 2010, Pages 3656-3664

  Reijmers, Rogier M ^a   Vondenhoff, Mark F R ^b   Roozendaal, Ramon ^b   Kuil, Annemieke ^a   Li, Jin Ping ^c   Spaargaren, Marcel ^a   Pals, Steven T ^a   Mebius, Reina E ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; CHEMOKINE; CYTOKINE; EPIMERASE; GLUCURONYL C5 EPIMERASE; HEPARAN SULFATE; PROTEOGLYCAN; UNCLASSIFIED DRUG; PROTEOHEPARAN SULFATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; DRUG ACTIVITY; EMBRYO; ENZYME ACTIVITY; ENZYME MODIFICATION; HEMATOPOIETIC CELL; HEMATOPOIETIC STEM CELL; LYMPH NODE; LYMPHOID ORGAN; MESENCHYME CELL; MORPHOGENESIS; MOUSE; NONHUMAN; ORGANOGENESIS; PRIMORDIUM; PRIORITY JOURNAL; SPLEEN; THYMUS; WILD TYPE; ANIMAL; CELL SEPARATION; ENZYMOLOGY; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOLOGY; LYMPHOID TISSUE; METABOLISM; MOUSE MUTANT; PRENATAL DEVELOPMENT;

ANIMALS; CARBOHYDRATE EPIMERASES; CELL SEPARATION; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HEPARAN SULFATE PROTEOGLYCANS; LYMPHOID TISSUE; MICE; MICE, KNOCKOUT; ORGANOGENESIS;

EID: 77951631057     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0902200     Document Type: Article

References (70)

1. Moore, M. A. 2004. Commentary: the role of cell migration in the ontogeny of the lymphoid system. Stem Cells Dev. 13: 1-21. (Pubitemid 38560038)
2. Vondenhoff, M. F., G. Kraal, and R. E. Mebius. 2007. Lymphoid organogenesis in brief. Eur. J. Immunol. 37: S46-S52.
3. Mebius, R. E. 2003. Organogenesis of lymphoid tissues. Nat. Rev. Immunol. 3: 292-303.
4. Yoshida, H., A. Naito, J. Inoue, M. Satoh, S. M. Santee-Cooper, C. F. Ware, A. Togawa, S. Nishikawa, and S. Nishikawa. 2002. Different cytokines induce surface lymphotoxin-alphabeta on IL-7 receptor-alpha cells that differentially engender lymph nodes and Peyer's patches. Immunity 17: 823-833. (Pubitemid 35477800)
5. - cells induce Peyer's patch development: role of alpha4beta1 integrin activation by CXCR5. Immunity 17: 363-373.
6. Honda, K., H. Nakano, H. Yoshida, S. Nishikawa, P. Rennert, K. Ikuta, M. Tamechika, K. Yamaguchi, T. Fukumoto, T. Chiba, and S. I. Nishikawa. 2001. Molecular basis for hematopoietic/mesenchymal interaction during initiation of Peyer's patch organogenesis. J. Exp. Med. 193: 621-630.
7. Adachi, S., H. Yoshida, K. Honda, K. Maki, K. Saijo, K. Ikuta, T. Saito, and S. I. Nishikawa. 1998. Essential role of IL-7 receptor alpha in the formation of Peyer's patch anlage. Int. Immunol. 10: 1-6.
8. Adachi, S., H. Yoshida, H. Kataoka, and S. Nishikawa. 1997. Three distinctive steps in Peyer's patch formation of murine embryo. Int. Immunol. 9: 507-514.
9. Cupedo, T., F. E. Lund, V. N. Ngo, T. D. Randall, W. Jansen, M. J. Greuter, R. de Waal-Malefyt, G. Kraal, J. G. Cyster, and R. E. Mebius. 2004. Initiation of cellular organization in lymph nodes is regulated by non-B cell-derived signals and is not dependent on CXC chemokine ligand 13. J. Immunol. 173: 4889-4896. (Pubitemid 39387770)
10. Luther, S. A., K. M. Ansel, and J. G. Cyster. 2003. Overlapping roles of CXCL13, interleukin 7 receptor alpha, and CCR7 ligands in lymph node development. J. Exp. Med. 197: 1191-1198.
11. Ohl, L., G. Henning, S. Krautwald, M. Lipp, S. Hardtke, G. Bernhardt, O. Pabst, and R. Förster. 2003. Cooperating mechanisms of CXCR5 and CCR7 in development and organization of secondary lymphoid organs. J. Exp. Med. 197: 1199-1204.
12. Dejardin, E., N. M. Droin, M. Delhase, E. Haas, Y. Cao, C. Makris, Z. W. Li, M. Karin, C. F. Ware, and D. R. Green. 2002. The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways. Immunity 17: 525-535. (Pubitemid 35223540)
13. Ansel, K. M., V. N. Ngo, P. L. Hyman, S. A. Luther, R. Förster, J. D. Sedgwick, J. L. Browning, M. Lipp, and J. G. Cyster. 2000. A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature 406: 309-314.
14. Rennert, P. D., D. James, F. Mackay, J. L. Browning, and P. S. Hochman. 1998. Lymph node genesis is induced by signaling through the lymphotoxin beta receptor. Immunity 9: 71-79. (Pubitemid 28361296)
15. Khan, S. A., M. S. Nelson, C. Pan, P. M. Gaffney, and P. Gupta. 2008. Endogenous heparan sulfate and heparin modulate bone morphogenetic protein-4 signaling and activity. Am. J. Physiol. Cell Physiol. 294: C1387-C1397.
16. Derksen, P. W., R. M. Keehnen, L. M. Evers, M. H. van Oers, M. Spaargaren, and S. T. Pals. 2002. Cell surface proteoglycan syndecan-1 mediates hepatocyte growth factor binding and promotes Met signaling in multiple myeloma. Blood 99: 1405-1410.
17. van derVoort, R., R. M. Keehnen, E. A. Beuling, M. Spaargaren, and S. T. Pals. 2000. Regulation of cytokine signaling by B cell antigen receptor and CD40-controlled expression of heparan sulfate proteoglycans. J. Exp. Med. 192: 1115-1124.
18. van der Voort, R., T. E. Taher, V. J. Wielenga, M. Spaargaren, R. Prevo, L. Smit, G. David, G. Hartmann, E. Gherardi, and S. T. Pals. 1999. Heparan sulfate-modified CD44 promotes hepatocyte growth factor/scatter factor-induced signal transduction through the receptor tyrosine kinase c-Met. J. Biol. Chem. 274: 6499-6506.
19. Lindahl, U., M. Kusche-Gullberg, and L. Kjellén. 1998. Regulated diversity of heparan sulfate. J. Biol. Chem. 273: 24979-24982.
20. Bishop, J. R., M. Schuksz, and J. D. Esko. 2007. Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature 446: 1030-1037.
21. Girardin, E. P., S. Hajmohammadi, B. Birmele, A. Helisch, N. W. Shworak, and A. I. de Agostini. 2005. Synthesis of anticoagulantly active heparan sulfate proteoglycans by glomerular epithelial cells involves multiple 3-O-sulfotransferase isoforms and a limiting precursor pool. J. Biol. Chem. 280: 38059-38070.
22. Reijmers, R. M., R. W. Groen, H. Rozemuller, A. Kuil, A. de Haan-Kramer, T. Csikós, A. C. Martens, M. Spaargaren, and S. T. Pals. 2010. Targeting EXT1 reveals a crucial role for heparan sulfate in the growth of multiple myeloma. Blood 115: 601-604 .
23. Belenkaya, T. Y., C. Han, D. Yan, R. J. Opoka, M. Khodoun, H. Liu, and X. Lin. 2004. Drosophila Dpp morphogen movement is independent of dynamin-mediated endocytosis but regulated by the glypican members of heparan sulfate proteoglycans. Cell 119: 231-244.
24. Aviezer, D., D. Hecht, M. Safran, M. Eisinger, G. David, and A. Yayon. 1994. Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis. Cell 79: 1005-1013.
25. -/- mutant mouse. J. Biol. Chem. 276: 35429-35434.
26. Ringvall, M., J. Ledin, K. Holmborn, T. van Kuppevelt, F. Ellin, I. Eriksson, A. M. Olofsson, L. Kjellen, and E. Forsberg. 2000. Defective heparan sulfate biosynthesis and neonatal lethality inmice lackingN-deacetylase/N- sulfotransferase-1. J. Biol. Chem. 275: 25926-25930.
27. Pilia, G., R. M. Hughes-Benzie, A. MacKenzie, P. Baybayan, E. Y. Chen, R. Huber, G. Neri, A. Cao, A. Forabosco, and D. Schlessinger. 1996. Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome. Nat. Genet. 12: 241-247.
28. Handel, T. M., Z. Johnson, S. E. Crown, E. K. Lau, and A. E. Proudfoot. 2005. Regulation of protein function by glycosaminoglycans - as exemplified by chemokines. Annu. Rev. Biochem. 74: 385-410.
29. Li, J.-P., F. Gong, A. Hagner-McWhirter, E. Forsberg, M. Abrink, R. Kisilevsky, X. Zhang, and U. Lindahl. 2003. Targeted disruption of a murine glucuronyl C5- epimerase gene results in heparan sulfate lacking L-iduronic acid and in neonatal lethality. J. Biol. Chem. 278: 28363-28366.
30. Mulloy, B., and M. J. Forster. 2000. Conformation and dynamics of heparin and heparan sulfate. Glycobiology 10: 1147-1156.
31. Kurup, S., T. J. Wijnhoven, G. J. Jenniskens, K. Kimata, H. Habuchi, J.-P. Li, U. Lindahl, T. H. van Kuppevelt, and D. Spillmann. 2007. Characterization of anti-heparan sulfate phage display antibodies AO4B08 and HS4E4. J. Biol. Chem. 282: 21032-21042.
32. Jia, J., M. Maccarana, X. Zhang, M. Bespalov, U. Lindahl, and J.-P. Li. 2009. Lack of L-iduronic acid in heparan sulfate affects interaction with growth factors and cell signaling. J. Biol. Chem. 284: 15942-15950.
33. Mebius, R. E., J. Brevé, G. Kraal, and P. R. Streeter. 1993. Developmental regulation of vascular addressin expression: a possible role for site-associated environments. Int. Immunol. 5: 443-449.
34. Tsai, P. T., R. A. Lee, and H. Wu. 2003. BMP4 acts upstream of FGF in modulating thymic stroma and regulating thymopoiesis. Blood 102: 3947-3953.
35. Bleul, C. C., and T. Boehm. 2005. BMP signaling is required for normal thymus development. J. Immunol. 175: 5213-5221. (Pubitemid 41456406)
36. Revest, J. M., R. K. Suniara, K. Kerr, J. J. Owen, and C. Dickson. 2001. Development of the thymus requires signaling through the fibroblast growth factor receptor R2-IIIb. J. Immunol. 167: 1954-1961.
37. Dooley, J., M. Erickson, W. J. Larochelle, G. O. Gillard, and A. G. Farr. 2007. FGFR2IIIb signaling regulates thymic epithelial differentiation. Dev. Dyn. 236: 3459-3471.
38. van Ewijk, W., G. Holländer, C. Terhorst, and B. Wang. 2000. Stepwise development of thymic microenvironments in vivo is regulated by thymocyte subsets. Development 127: 1583-1591.
39. Anderson, G., N. C. Moore, J. J. Owen, and E. J. Jenkinson. 1996. Cellular interactions in thymocyte development. Annu. Rev. Immunol. 14: 73-99.
40. Hogquist, K. A., and M. J. Bevan. 1996. The nature of the peptide/MHC ligand involved in positive selection. Semin. Immunol. 8: 63-68.
41. Farr, A. G., S. K. Anderson, P. Marrack, and J. Kappler. 1985. Expression of antigen-specific, major histocompatibility complex-restricted receptors by cortical and medullary thymocytes in situ. Cell 43: 543-550.
42. Xiao, S. Y., Y. Li, and W. F. Chen. 2003. Kinetics of thymocyte developmental process in fetal and neonatal mice. Cell Res. 13: 265-273.
43. Bertrand, J. Y., G. E. Desanti, R. Lo-Man, C. Leclerc, A. Cumano, and R. Golub. 2006. Fetal spleen stroma drives macrophage commitment. Development 133: 3619-3628.
44. Withers, D. R., M. Y. Kim, V. Bekiaris, S. W. Rossi, W. E. Jenkinson, F. Gaspal, F. McConnell, J. H. Caamano, G. Anderson, and P. J. Lane. 2007. The role of lymphoid tissue inducer cells in splenic white pulp development. Eur. J. Immunol. 37: 3240-3245.
45. Vondenhoff, M. F., G. E. Desanti, T. Cupedo, J. Y. Bertrand, A. Cumano, G. Kraal, R. E. Mebius, and R. Golub. 2008. Separation of splenic red and white pulp occurs before birth in a LTalphabeta-independent manner. J. Leukoc. Biol. 84: 152-161.
46. van de Pavert, S. A., B. J. Olivier, G. Goverse, M. F. Vondenhoff, M. Greuter, P. Beke, K. Kusser, U. E. Höpken, M. Lipp, K. Niederreither, et al. 2009. Chemokine CXCL13 is essential for lymph node initiation and is induced by retinoic acid and neuronal stimulation. Nat. Immunol. 10: 1193-1199.
47. Tangemann, K., M. D. Gunn, P. Giblin, and S. D. Rosen. 1998. A high endothelial cell-derived chemokine induces rapid, efficient, and subset-selective arrest of rolling T lymphocytes on a reconstituted endothelial substrate. J. Immunol. 161: 6330-6337. (Pubitemid 28536009)
48. Gallet, A., L. Staccini-Lavenant, and P. P. Thérond. 2008. Cellular trafficking of the glypican Dally-like is required for full-strength Hedgehog signaling and wingless transcytosis. Dev. Cell 14: 712-725. (Pubitemid 351622609)
49. Takei, Y., Y. Ozawa, M. Sato, A. Watanabe, and T. Tabata. 2004. Three Drosophila EXT genes shape morphogen gradients through synthesis of heparan sulfate proteoglycans. Development 131: 73-82. (Pubitemid 38111416)
50. Giráldez, A. J., R. R. Copley, and S. M. Cohen. 2002. HSPG modification by the secreted enzyme Notum shapes the Wingless morphogen gradient. Dev. Cell 2: 667-676.
51. Blackburn, C. C., and N. R. Manley. 2004. Developing a new paradigm for thymus organogenesis. Nat. Rev. Immunol. 4: 278-289.
52. Hu, Z., C. Wang, Y. Xiao, N. Sheng, Y. Chen, Y. Xu, L. Zhang, W. Mo, N. Jing, and G. Hu. 2009. NDST1-dependent heparan sulfate regulates BMP signaling and internalization in lung development. J. Cell Sci. 122: 1145-1154.
53. Olivares, G. H., H. Carrasco, F. Aroca, L. Carvallo, F. Segovia, and J. Larraín. 2009. Syndecan-1 regulates BMP signaling and dorso-ventral patterning of the ectoderm during early Xenopus development. Dev. Biol. 329: 338-349.
54. Dunn, N. R., G. E. Winnier, L. K. Hargett, J. J. Schrick, A. B. Fogo, and B. L. M. Hogan. 1997. Haploinsufficient phenotypes in Bmp4 heterozygous null mice and modification by mutations in Gli3 and Alx4. Dev. Biol. 188: 235-247.
55. Chang, B., R. S. Smith, M. Peters, O. V. Savinova, N. L. Hawes, A. Zabaleta, S. Nusinowitz, J. E. Martin, M. L. Davisson, C. L. Cepko, et al. 2001. Haploinsufficient Bmp4 ocular phenotypes include anterior segment dysgenesis with elevated intraocular pressure. BMC Genet. 2: 18.
56. Hwang, C. H., and D. K. Wu. 2008. Noggin heterozygous mice: an animal model for congenital conductive hearing loss in humans. Hum. Mol. Genet. 17: 844-853.
57. Alves, N. L., O. Richard-Le Goff, N. D. Huntington, A. P. Sousa, V. S. Ribeiro, A. Bordack, F. L. Vives, L. Peduto, A. Chidgey, A. Cumano, et al. 2009. Characterization of the thymic IL-7 niche in vivo. Proc. Natl. Acad. Sci. USA 106: 1512-1517.
58. Schwarz, B. A., A. Sambandam, I. Maillard, B. C. Harman, P. E. Love, and A. Bhandoola. 2007. Selective thymus settling regulated by cytokine and chemokine receptors. J. Immunol. 178: 2008-2017.
59. Liu, C., F. Saito, Z. Liu, Y. Lei, S. Uehara, P. Love, M. Lipp, S. Kondo, N. Manley, and Y. Takahama. 2006. Coordination between CCR7- and CCR9- mediated chemokine signals in prevascular fetal thymus colonization. Blood 108: 2531-2539.
60. Ara, T., M. Itoi, K. Kawabata, T. Egawa, K. Tokoyoda, T. Sugiyama, N. Fujii, T. Amagai, and T. Nagasawa. 2003. A role of CXC chemokine ligand 12/stromal cell-derived factor-1/pre-B cell growth stimulating factor and its receptor CXCR4 in fetal and adult T cell development in vivo. J. Immunol. 170: 4649-4655. (Pubitemid 36519971)
61. de Paz, J. L., E. A. Moseman, C. Noti, L. Polito, U. H. von Andrian, and P. H. Seeberger. 2007. Profiling heparin-chemokine interactions using synthetic tools. ACS Chem. Biol. 2: 735-744.
62. Sadir, R., A. Lambert, H. Lortat-Jacob, and G. Morel. 2001. Caveolae and clathrin- coated vesicles: two possible internalization pathways for IFN-gamma and IFN-gamma receptor. Cytokine 14: 19-26. (Pubitemid 32579269)
63. Amara, A., O. Lorthioir, A. Valenzuela, A. Magerus, M. Thelen, M. Montes, J. L. Virelizier, M. Delepierre, F. Baleux, H. Lortat-Jacob, and F. Arenzana- Seisdedos. 1999. Stromal cell-derived factor-1alpha associates with heparan sulfates through the first beta-strand of the chemokine. J. Biol. Chem. 274: 23916-23925.
64. Rueda, P., K. Balabanian, B. Lagane, I. Staropoli, K. Chow, A. Levoye, C. Laguri, R. Sadir, T. Delaunay, E. Izquierdo, et al. 2008. The CXCL12gamma chemokine displays unprecedented structural and functional properties that make it a paradigm of chemoattractant proteins. PLoS One 3: e2543.
65. Abramsson, A., S. Kurup, M. Busse, S. Yamada, P. Lindblom, E. Schallmeiner, D. Stenzel, D. Sauvaget, J. Ledin, M. Ringvall, et al. 2007. Defective N-sulfation of heparan sulfate proteoglycans limits PDGF-BB binding and pericyte recruitment in vascular development. Genes Dev. 21: 316-331.
66. Chang, L. K., G. Garcia-Cardeña, F. Farnebo, M. Fannon, E. J. Chen, C. Butterfield, M. A. Moses, R. C. Mulligan, J. Folkman, and A. Kaipainen. 2004. Dose-dependent response of FGF-2 for lymphangiogenesis. Proc. Natl. Acad. Sci. USA 101: 11658-11663.
67. Katoh-Fukui, Y., A. Owaki, Y. Toyama, M. Kusaka, Y. Shinohara, M. Maekawa, K. Toshimori, and K. Morohashi. 2005. Mouse Polycomb M33 is required for splenic vascular and adrenal gland formation through regulating Ad4BP/SF1 expression. Blood 106: 1612-1620. (Pubitemid 41208573)
68. Yang, B. G., T. Tanaka, M. H. Jang, Z. Bai, H. Hayasaka, and M. Miyasaka. 2007. Binding of lymphoid chemokines to collagen IV that accumulates in the basal lamina of high endothelial venules: its implications in lymphocyte trafficking. J. Immunol. 179: 4376-4382.
69. Ma, B., J. Jablonska, W. Lindenmaier, and K. E. Dittmar. 2007. Immunohistochemical study of the reticular and vascular network of mouse lymph node using vibratome sections. Acta Histochem. 109: 15-28. (Pubitemid 46176048)
70. Sixt, M., N. Kanazawa, M. Selg, T. Samson, G. Roos, D. P. Reinhardt, R. Pabst, M. B. Lutz, and L. Sorokin. 2005. The conduit system transports soluble antigens from the afferent lymph to resident dendritic cells in the T cell area of the lymph node. Immunity 22: 19-29. (Pubitemid 40143448)